sounds like eyedrops
seems cheap, they would be working on getting a 30% return on investment
the big advantage ELX. have is its existing distribution and marketing channels. By slotting another product in you are simply leveraging off the existing infrastructure. A smaller player has to give away a lot of margin to distribute/market
thats how I see it. 2014 should be a great year for ELX, esp if the Aussie hits 80c, it will dramatically boost the bottom line
ellex acquisition company inc, page-11
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
-0.025(8.62%) |
Mkt cap ! $60.63M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 26.5¢ | $332.8K | 1.182M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 121450 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 154073 | 4 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |